BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4823395)

  • 1. Change in glucose and insulin after six months' treatment with the oral contraceptive Demulen.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Am J Obstet Gynecol; 1974 May; 119(2):266-7. PubMed ID: 4823395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
    Spellacy WN; Tsibris JC; Hunter-Bonner DL; Smalling S; Chez RA; Angel JL; O'Brien WF
    Contraception; 1992 Jun; 45(6):533-9. PubMed ID: 1617962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ethynodiol diacetate and a combination-type oral contraceptive compound on carbohydrate metabolism. II. One year intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1977 Apr; 13(2):89-91. PubMed ID: 856654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.
    Spellacy WN; Tsibris AM; Tsibris JC; George S; Chez RA; O'Brien WF
    Contraception; 1994 Feb; 49(2):125-30. PubMed ID: 8143452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of desogestrel on carbohydrate metabolism.
    Shoupe D
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1041-7. PubMed ID: 8447358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate metabolism studies in women using Brevicon, a low-estrogen type of oral contraceptive, for one year.
    Spellacy WN; Buhi WC; Birk SA; Van Arnarn JB
    Am J Obstet Gynecol; 1982 Jan; 142(1):105-8. PubMed ID: 7034537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. I. Carbohydrate metabolism and liver function.
    Ahrén T; Victor A; Lithell H; Johansson ED
    Contraception; 1981 Oct; 24(4):415-27. PubMed ID: 6797784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of oral contraceptives in monkeys fed on adequate and low protein diets.
    Nutr Rev; 1974 May; 32(5):149-52. PubMed ID: 4208157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a "low-estrogen" oral contraceptive on carbohydrate metabolism during six months of treatment: a preliminary report of blood glucose and plasma insulin values.
    Spellacy WN; Newton RE; Buhi WC; Birk SA
    Fertil Steril; 1977 Aug; 28(8):885-7. PubMed ID: 328310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO; Andersen O; Kühl C
    Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.